BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26461473)

  • 1. Regulation of SOX10 stability via ubiquitination-mediated degradation by Fbxw7α modulates melanoma cell migration.
    Lv XB; Wu W; Tang X; Wu Y; Zhu Y; Liu Y; Cui X; Chu J; Hu P; Li J; Guo Q; Cai Z; Wu J; Hu K; Ouyang N
    Oncotarget; 2015 Nov; 6(34):36370-82. PubMed ID: 26461473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FBXW7 modulates cellular stress response and metastatic potential through ​HSF1 post-translational modification.
    Kourtis N; Moubarak RS; Aranda-Orgilles B; Lui K; Aydin IT; Trimarchi T; Darvishian F; Salvaggio C; Zhong J; Bhatt K; Chen EI; Celebi JT; Lazaris C; Tsirigos A; Osman I; Hernando E; Aifantis I
    Nat Cell Biol; 2015 Mar; 17(3):322-332. PubMed ID: 25720964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation.
    Kanei-Ishii C; Nomura T; Takagi T; Watanabe N; Nakayama KI; Ishii S
    J Biol Chem; 2008 Nov; 283(45):30540-8. PubMed ID: 18765672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CK1δ/GSK3β/FBXW7α axis promotes degradation of the ZNF322A oncoprotein to suppress lung cancer progression.
    Liao SY; Chiang CW; Hsu CH; Chen YT; Jen J; Juan HF; Lai WW; Wang YC
    Oncogene; 2017 Oct; 36(41):5722-5733. PubMed ID: 28581525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of Fbw7 in human melanoma and its role in cell migration.
    Cheng Y; Chen G; Martinka M; Ho V; Li G
    J Invest Dermatol; 2013 Jul; 133(7):1794-802. PubMed ID: 23381582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin Ligase, Fbw7, Targets CDX2 for Degradation via Two Phosphodegron Motifs in a GSK3β-Dependent Manner.
    Kumar Y; Shukla N; Thacker G; Kapoor I; Lochab S; Bhatt ML; Chattopadhyay N; Sanyal S; Trivedi AK
    Mol Cancer Res; 2016 Nov; 14(11):1097-1109. PubMed ID: 27470268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma.
    Busino L; Millman SE; Scotto L; Kyratsous CA; Basrur V; O'Connor O; Hoffmann A; Elenitoba-Johnson KS; Pagano M
    Nat Cell Biol; 2012 Mar; 14(4):375-85. PubMed ID: 22388891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin ligase SCF
    Song N; Cao C; Tang Y; Bi L; Jiang Y; Zhou Y; Song X; Liu L; Ge W
    J Cell Physiol; 2018 Mar; 233(3):2366-2377. PubMed ID: 28722108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells.
    Zhao J; Wang Y; Mu C; Xu Y; Sang J
    Oncogene; 2017 Aug; 36(35):5023-5034. PubMed ID: 28459460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX10 expression in superficial spreading and nodular malignant melanomas.
    Agnarsdóttir M; Sooman L; Bolander A; Strömberg S; Rexhepaj E; Bergqvist M; Ponten F; Gallagher W; Lennartsson J; Ekman S; Uhlen M; Hedstrand H
    Melanoma Res; 2010 Dec; 20(6):468-78. PubMed ID: 20890226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.
    Zhao D; Zheng HQ; Zhou Z; Chen C
    Cancer Res; 2010 Jun; 70(11):4728-38. PubMed ID: 20484041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fbxo9 functions downstream of Sox10 to determine neuron-glial fate choice in the dorsal root ganglia through Neurog2 destabilization.
    Liu JA; Tai A; Hong J; Cheung MPL; Sham MH; Cheah KSE; Cheung CW; Cheung M
    Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4199-4210. PubMed ID: 32029586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion.
    Graf SA; Heppt MV; Wessely A; Krebs S; Kammerbauer C; Hornig E; Strieder A; Blum H; Bosserhoff AK; Berking C
    Pigment Cell Melanoma Res; 2019 May; 32(3):424-434. PubMed ID: 30506895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sox10 regulates skin melanocyte proliferation by activating the DNA replication licensing factor MCM5.
    Su Z; Zheng X; Zhang X; Wang Y; Zhu S; Lu F; Qu J; Hou L
    J Dermatol Sci; 2017 Mar; 85(3):216-225. PubMed ID: 27955842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two distinct E3 ligases, SCF
    Liu J; Dong S; Wang H; Li L; Ye Q; Li Y; Miao J; Jhiang S; Zhao J; Zhao Y
    FASEB J; 2019 Sep; 33(9):10538-10550. PubMed ID: 31238008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCF(FBXW7α) modulates the intra-S-phase DNA-damage checkpoint by regulating Polo like kinase-1 stability.
    Giráldez S; Herrero-Ruiz J; Mora-Santos M; Japón MÁ; Tortolero M; Romero F
    Oncotarget; 2014 Jun; 5(12):4370-83. PubMed ID: 24970797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fbw7 promotes ubiquitin-dependent degradation of c-Myb: involvement of GSK3-mediated phosphorylation of Thr-572 in mouse c-Myb.
    Kitagawa K; Hiramatsu Y; Uchida C; Isobe T; Hattori T; Oda T; Shibata K; Nakamura S; Kikuchi A; Kitagawa M
    Oncogene; 2009 Jun; 28(25):2393-405. PubMed ID: 19421138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX9 is a dose-dependent metastatic fate determinant in melanoma.
    Yang X; Liang R; Liu C; Liu JA; Cheung MPL; Liu X; Man OY; Guan XY; Lung HL; Cheung M
    J Exp Clin Cancer Res; 2019 Jan; 38(1):17. PubMed ID: 30642390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.
    Shakhova O; Cheng P; Mishra PJ; Zingg D; Schaefer SM; Debbache J; Häusel J; Matter C; Guo T; Davis S; Meltzer P; Mihic-Probst D; Moch H; Wegner M; Merlino G; Levesque MP; Dummer R; Santoro R; Cinelli P; Sommer L
    PLoS Genet; 2015 Jan; 11(1):e1004877. PubMed ID: 25629959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity.
    Graf SA; Busch C; Bosserhoff AK; Besch R; Berking C
    J Invest Dermatol; 2014 Aug; 134(8):2212-2220. PubMed ID: 24608986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.